Neuberger Berman Group’s Accretive Health AH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,520,487
| Closed | -$3.42M | – | 1702 |
|
|
2016
Q4 | $3.42M | Sell |
1,520,487
-41,006
| -3% | -$92.3K | ﹤0.01% | 914 |
|
|
2016
Q3 | $3.81M | Sell |
1,561,493
-38,338
| -2% | -$93.5K | 0.01% | 878 |
|
|
2016
Q2 | $3.2M | Sell |
1,599,831
-19,750
| -1% | -$39.5K | ﹤0.01% | 903 |
|
|
2016
Q1 | $4.13M | Sell |
1,619,581
-48,172
| -3% | -$123K | 0.01% | 881 |
|
|
2015
Q4 | $5.34M | Sell |
1,667,753
-59,041
| -3% | -$189K | 0.01% | 876 |
|
|
2015
Q3 | $4.28M | Sell |
1,726,794
-9,099
| -0.5% | -$22.6K | 0.01% | 906 |
|
|
2015
Q2 | $9.55M | Sell |
1,735,893
-16,413
| -0.9% | -$90.3K | 0.01% | 840 |
|
|
2015
Q1 | $10.1M | Buy |
1,752,306
+19,424
| +1% | +$112K | 0.01% | 829 |
|
|
2014
Q4 | $11.9M | Buy |
1,732,882
+292,965
| +20% | +$2.01M | 0.01% | 792 |
|
|
2014
Q3 | $11.2M | Buy |
1,439,917
+28,345
| +2% | +$220K | 0.01% | 815 |
|
|
2014
Q2 | $11M | Buy |
1,411,572
+13,383
| +1% | +$104K | 0.01% | 812 |
|
|
2014
Q1 | $11.2M | Buy |
1,398,189
+89,356
| +7% | +$791K | 0.01% | 782 |
|
|
2013
Q4 | $12M | Buy |
1,308,833
+222,262
| +20% | +$1.91M | 0.01% | 766 |
|
|
2013
Q3 | $9.91M | Buy |
1,086,571
+590,790
| +119% | +$5.87M | 0.01% | 788 |
|
|
2013
Q2 | $5.36M | Buy |
+495,781
| New | +$5.22M | 0.01% | 874 |
|
Neuberger Berman Group's AH Position: Q1 2017 in Review
Neuberger Berman Group sold out of Accretive Health (AH) in Q1 2017, closing a stake of 1,520,487 shares — an estimated $3.42M sold.
Neuberger Berman Group first reported a position in AH in Q2 2013 and held it in 15 quarters. The position peaked at $12M in Q4 2013. 0 funds tracked by Wall St. Rank hold AH as of Q1 2017.
- Neuberger Berman Group reported no remaining Accretive Health position as of Q1 2017 after selling out during the quarter.
- Neuberger Berman Group sold 1,520,487 Accretive Health shares in Q1 2017, an estimated $3.42M.
- Neuberger Berman Group first reported a position in Accretive Health in Q2 2013 and held it in 15 quarters.
- Neuberger Berman Group's Accretive Health position peaked at $12M in Q4 2013.
- 0 funds tracked by Wall St. Rank held Accretive Health as of Q1 2017.
Based on Neuberger Berman Group's 13F filing for Q1 2017, filed 10 May 2017.